|
|
|
|
|
by xeckr
960 days ago
|
|
The FDA's press release didn't say anything about the success rate, only that the test group had significantly lower levels of depression than the control group. It's true that a lot of antidepressants fail to improve symptoms in a lot of people. The effectiveness of this particular drug better be outstanding, otherwise Biogen-Sage won't be able to justify the high price compared to other antidepressants. |
|